1 enrolling by invitation. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow SRP-1001 for Injection: new trials by email Literature Review of SRP-1001 for Injection trials Research Report on SRP-1001 for Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1 SRP-1001 for Injection, Placebo - Muscular Dystrophy, Facioscapulohumeral | Phase 1 / Phase 2 | Enrolling by invitation | Sarepta Therapeutics, Inc. | 60 | 2024-06-19 | 2026-10-05 |
Muscular Dystrophy, Facioscapulohumeral (1)
Sarepta Therapeutics, Inc. (1)
Australia (1) · Canada (1) · Germany (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Spain (1)
2023 (1)